Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.94 USD | -0.42% | -4.88% | +637.50% |
Jun. 03 | Corbus Pharmaceuticals Reaches 2-Year High After Drug Results | DJ |
Jun. 03 | Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $80 From $60, Maintains Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+637.50% | 472M | |
+18.83% | 125B | |
+13.73% | 108B | |
-7.39% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-14.21% | 16.37B | |
+2.35% | 13.58B | |
+28.13% | 11.66B |
- Stock Market
- Equities
- CRBP Stock
- News Corbus Pharmaceuticals Holdings, Inc.
- Jefferies Upgrades Corbus Pharmaceuticals Holdings to Buy From Hold